Munafa Stock Market Course + Intraday & FNO calls 
Crispr Therapeutics (CRSP) Technical (Analysis) Reports Crispr Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Crispr Therapeutics (CRSP)
Technical Analysis Report for USA stock CRSP Crispr Therapeutics. Dated: 06 Feb 2026 Updated Daily. Stock trades under Health Care Deals in Biotechnology Biological Products No Diagnostic Substances in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock CRSP Crispr Therapeutics then click here. or read Experts views on Crispr Therapeutics or Forecast & share price targets of Crispr Therapeutics
Crispr Therapeutics Opened at 46.02 and Closed at: 48.78, which is 5.95% of previous session's close. It moved within a range of 45.00 and 48.99
The session was a Bullish session with an average volume of 879833, which is -197.91% of previous session's volumes.
- Even though the stock has shown an up move, but the short term trend of the stock remains negative and in a downtrend.
- The stock has shown an up move, and its long term trend is also positive and in an uptrend.
A Dead cross was found 8 days back on short term averages
A Dead cross was found 7 days back on mid term averages
A Dead cross was found 1 days back on long term averages
Support for tomorrow is 46.89 and resistance for tomorrow is 50.88
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 46.19, 43.6 resistance for tomorrow's hourly charts is 50.18, 51.58
10 Day SMA for Crispr Therapeutics (CRSP) is 51.4 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Crispr Therapeutics (CRSP) is 53.38 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Crispr Therapeutics (CRSP) is 54.68 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 58.63 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Crispr Therapeutics is 53.55 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Crispr Therapeutics is at 53.38 and 200 DMA is at 53.55, while 50 DMA and 100 DMA are at 54.68 and 58.63 respectively
Crispr Therapeutics (CRSP) moving average of 20 SMA is at 53.38 and 20 EMA is at 52.53
| Date | Closing Price | 20 SMA | 20 EMA |
| 06 Fri Feb | 48.78 | 53.38 | 52.53 |
| 05 Thu Feb | 45.88 | 53.76 | 52.93 |
| 04 Wed Feb | 50.17 | 54.37 | 53.67 |
| 03 Tue Feb | 52.00 | 54.77 | 54.04 |
| 02 Mon Feb | 51.32 | 54.92 | 54.26 |
| 30 Fri Jan | 49.95 | 55.05 | 54.57 |
Crispr Therapeutics (CRSP) moving average of 50 SMA is at 54.68 and 50 EMA is at 54.56
| Date | Closing Price | 50 SMA | 50 EMA |
| 06 Fri Feb | 48.78 | 54.68 | 54.56 |
| 05 Thu Feb | 45.88 | 54.73 | 54.8 |
| 04 Wed Feb | 50.17 | 54.82 | 55.16 |
| 03 Tue Feb | 52.00 | 54.8 | 55.36 |
| 02 Mon Feb | 51.32 | 54.78 | 55.5 |
| 30 Fri Jan | 49.95 | 54.82 | 55.67 |
Crispr Therapeutics (CRSP) moving average of 100 SMA is at 58.63 and 100 EMA is at 55.43
| Date | Closing Price | 100 SMA | 100 EMA |
| 06 Fri Feb | 48.78 | 58.63 | 55.43 |
| 05 Thu Feb | 45.88 | 58.72 | 55.56 |
| 04 Wed Feb | 50.17 | 58.83 | 55.76 |
| 03 Tue Feb | 52.00 | 58.88 | 55.87 |
| 02 Mon Feb | 51.32 | 58.88 | 55.95 |
| 30 Fri Jan | 49.95 | 58.9 | 56.04 |
Crispr Therapeutics (CRSP) moving average of 200 SMA is at 53.55 and 200 EMA is at 54.19
| Date | Closing Price | 200 SMA | 200 EMA |
| 06 Fri Feb | 48.78 | 53.55 | 54.19 |
| 05 Thu Feb | 45.88 | 53.5 | 54.24 |
| 04 Wed Feb | 50.17 | 53.46 | 54.32 |
| 03 Tue Feb | 52.00 | 53.4 | 54.36 |
| 02 Mon Feb | 51.32 | 53.33 | 54.38 |
| 30 Fri Jan | 49.95 | 53.26 | 54.41 |
Penumbra Inc has performed better than Crispr Therapeutics in short term. You could have earned much better returns by investing in Penumbra Inc, about 15.16% more returns!
Novartis Ag has performed better than Crispr Therapeutics in short term. You could have earned much better returns by investing in Novartis Ag, about 19.91% more returns!
Msa Safety has performed better than Crispr Therapeutics in short term. You could have earned much better returns by investing in Msa Safety, about 20.41% more returns!
Quest Diagnostics has performed better than Crispr Therapeutics in short term. You could have earned much better returns by investing in Quest Diagnostics, about 18.73% more returns!
Savara Inc has performed better than Crispr Therapeutics in short term. You could have earned much better returns by investing in Savara Inc, about 0.62% more returns!
Sanofi has performed better than Crispr Therapeutics in short term. You could have earned much better returns by investing in Sanofi, about 6.95% more returns!
Crispr Therapeutics has performed better than Pacira Pharmaceuticals in short term. Holding Crispr Therapeutics could be a better choice for now!
Pavmed Inc has performed better than Crispr Therapeutics in short term. You could have earned much better returns by investing in Pavmed Inc, about 60.57% more returns!
Crispr Therapeutics has performed better than Omeros Corporation in short term. Holding Crispr Therapeutics could be a better choice for now!
Neogen Corporation has performed better than Crispr Therapeutics in short term. You could have earned much better returns by investing in Neogen Corporation, about 21.67% more returns!
Iradimed Corporation has performed better than Crispr Therapeutics in short term. You could have earned much better returns by investing in Iradimed Corporation, about 6.39% more returns!
Crispr Therapeutics has performed better than Inogen Inc in short term. Holding Crispr Therapeutics could be a better choice for now!
Crispr Therapeutics has performed better than Helius Medical in short term. Holding Crispr Therapeutics could be a better choice for now!
National Vision has performed better than Crispr Therapeutics in short term. You could have earned much better returns by investing in National Vision, about 19.19% more returns!
Exelixis Inc has performed better than Crispr Therapeutics in short term. You could have earned much better returns by investing in Exelixis Inc, about 9.08% more returns!
Dermira Inc has performed better than Crispr Therapeutics in short term. You could have earned much better returns by investing in Dermira Inc, about 24.26% more returns!
Crispr Therapeutics has performed better than Cue Biopharma in short term. Holding Crispr Therapeutics could be a better choice for now!
Caredx Inc has performed better than Crispr Therapeutics in short term. You could have earned much better returns by investing in Caredx Inc, about 23.06% more returns!
Crispr Therapeutics has performed better than Arbutus Biopharma in short term. Holding Crispr Therapeutics could be a better choice for now!
Crispr Therapeutics Technical analysis of indicators
Price action analysis of Crispr Therapeutics (CRSP) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Crispr Therapeutics stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Crispr Therapeutics in short term and the sell signal is strong.
Crispr Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Crispr Therapeutics in short term but BUY signal is weak.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Crispr Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 50.64 and Crispr Therapeutics CRSP stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Crispr Therapeutics CRSP stock. Volume based technical analysis of Crispr Therapeutics CRSP stock is negative.
Crispr Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock CRSP Crispr Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And CRSP Experts View which covers a lot of information including buying and selling signals
CRSP future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Crispr Therapeutics or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Crispr Therapeutics (CRSP) Technical (Analysis) Reports Crispr Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts
Hindi Video Most Important Stock Market Video. No Success Without This Formula
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance
